Class: Bronchodilator/Xanthine derivative
ANTI-ASTHMATIC AND COPD
Non-selective phosphodiesterase inhibitor
Etofylline should be used with caution in patients with severe cardiac disease, hypertension, acute myocardial injury, congestive heart failure, severe hypoxemia, hyperthyroidism, hepatic impairment, history of peptic ulcer, alcoholism and in the elderly.
Nervousness, agitation, headache, insomnia, nausea, vomiting, tachycardia, extrasystoles, hyperflexia, fasciculations and clonic and tonic convulsions occur on over dosage. Frequency of adverse reactions are related to serum levels.